Since 2011, Tad Roselund has served as Boston Consulting Group’s Chief Risk Officer, reporting to the firm's CEO and serving on the audit & risk committee. As CRO, Tad is responsible for identification of key risks to BCG and ensuring appropriate management strategies are in place to address them. He also leads the internal risk management function, co-leads the information security group, and oversees global data management/data privacy efforts.

In his 18 years of client service at BCG, much of Tad's work focuses on biopharmaceutical change efforts centered on organizational design, integration, and transformation. These programs involved all aspects of the biopharma value chain including R&D, sales and marketing, and various enabling functions.

In 2015, Tad founded BCG's internal operational innovations group, focused on driving and accelerating large change programs within BCG's internal functions.

Tad was previously a consultant with the LEK Partnership, developing M&A and corporate strategy on the health care, telecommunications, and media industries.

AREAS OF EXPERTISE

  • Corporate risk management and resilience
  • Organizational design
  • Change management and functional transformation
  • Biopharma: commercialization, post-merger integration

EDUCATION

  • MBA, Arjay Miller Scholar, Stanford University Graduate School of Business
  • BA, phi beta kappa, economics, Dartmouth College
Deep Expertise, Broad Experience